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Wnt5a is essential during embryonic development, as indicated by mouse Wnt5a knockout embryos
displaying outgrowth defects of multiple structures including the gut. The dynamics of Wnt5a involvement
in these processes is unclear, and perinatal lethality ofWnt5a knockout embryos has hampered investigation
of Wnt5a during postnatal stages in vivo. Although in vitro studies have suggested a relevant role for Wnt5a
postnatally, solid evidence for a signiﬁcant impact of Wnt5a within the complexity of an adult organism is
lacking. We generated a tightly-regulated inducible Wnt5a transgenic mouse model and investigated the
effects of Wnt5a induction during different time-frames of embryonic development and in adult mice,
focusing on the gastrointestinal tract. When induced in embryos from 10.5 dpc onwards, Wnt5a expression
led to severe outgrowth defects affecting the gastrointestinal tracts, limbs, facial structures and tails, closely
resembling the defects observed inWnt5a knockout mice. However, Wnt5a induction from 13.5 dpc onwards
did not cause this phenotype, indicating that the most critical period for Wnt5a in embryonic development is
prior to 13.5 dpc. In adult mice, induced Wnt5a expression did not reveal abnormalities, providing the ﬁrst
in vivo evidence that Wnt5a has no major impact on mouse intestinal homeostasis postnatally. Protein
expression of Wnt5a receptor Ror2 was strongly reduced in adult intestine compared to embryonic stages.
Moreover, we uncovered a regulatory process where induction of Wnt5a causes downregulation of its
receptor Ror2. Taken together, our results indicate a role for Wnt5a during a restricted time-frame of
embryonic development, but suggest no impact during homeostatic postnatal stages.
& 2012 Elsevier Inc. All rights reserved.Introduction
Whereas the relevance of canonical Wnt/b-catenin signaling in
intestinal homeostasis and cancer is well established (Albuquerque
et al., 2011; Reya and Clevers, 2005), the so-called non-canonical
Wnt signaling is far less understood. Non-canonical Wnt signaling
is represented by multiple alternative signaling routes that act
independent of b-catenin transcriptional activity and are typically
activated by non-canonical Wnt ligands. Wnt5a is the most
extensively studied non-canonical ligand and has gained substan-
tial attention over the last years as it is being implicated in various
human diseases including cancer, inﬂammatory diseases and
metabolic disorders (Kikuchi et al., 2011; Oh and Olefsky, 2010;ll rights reserved.
its).Pukrop and Binder, 2008). Signaling pathways that can be activated
by Wnt5a include Wnt/Ca2þ and Wnt/JNK pathways, also referred
to as the planar cell polarity pathway, are primarily known to
mediate oriented cell movements during development (Gros et al.,
2010; Kikuchi et al., 2011; Nishita et al., 2010a; Pukrop and Binder,
2008; Yamaguchi et al., 1999). Additionally, Wnt5a can inhibit
b-catenin signaling, although promoting effects have also been
demonstrated in receptor overexpression experiments (Mikels and
Nusse, 2006). Importantly, which pathway is actually activated by
Wnt5a greatly depends on the context, especially dictated by
receptor presence. The best characterized Wnt5a receptor is
receptor tyrosine kinase-like orphan receptor 2 (Ror2) (Green
et al., 2008; Mikels et al., 2009; Mikels and Nusse, 2006; Oishi
et al., 2003). Members of the family of Frizzled receptors, Ror1 and
receptor-like tyrosine kinase Ryk have also been implicated to act
as (co)receptors in Wnt5a signaling (Grumolato et al., 2010;
Kikuchi et al., 2011; Mikels and Nusse, 2006; Sato et al., 2010).
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indicated by the perinatal lethality of homozygousWnt5a knockout
mice (Yamaguchi et al., 1999). During development, Wnt5a expres-
sion is predominantly detected in structures undergoing extensive
outgrowth, including the limbs, tail and facial structures (Gavin
et al., 1990; Yamaguchi et al., 1999). Expression in these structures
is in a graded fashion with highest levels towards the outer tips
and most pronounced between 10 and 14 days post coitum (dpc)
(Gavin et al., 1990; Yamaguchi et al., 1999). Loss ofWnt5a results in
a drastic shortening of these structures in mouse embryos
(Yamaguchi et al., 1999). Importantly, the embryonic phenotype
of Ror2 homozygous knockout mice closely resembles the Wnt5a
knockout phenotype, although appearing milder (DeChiara et al.,
2000; Takeuchi et al., 2000). Thus, during embryonic development
both Wnt5a and its main receptor Ror2 are essential for the proper
outgrowth of multiple structures. This also applies to the gastro-
intestinal tract. Normal gut development involves temporal and
spatial speciﬁc expression of Wnt5a and Ror2. Both Wnt5a and
Ror2 expression peak between 10.5 and 13.5 dpc, a critical period
when midgut elongation occurs. Wnt5a expression is restricted to
the mesenchyme of the caudal midgut and rostral hindgut (i.e.
future distal small intestine and proximal large intestine), sug-
gested to correlate with regions of the small intestine that undergo
elongation (Cervantes et al., 2009; Lickert et al., 2001; Yamada
et al., 2010). Ror2 expression shows a complex region-speciﬁc
pattern in both the mesenchyme and epithelium (Yamada et al.,
2010). Homozygous knockout of either Wnt5a or Ror2 results in
shortened embryonic intestines, in addition to an imperforate anus
inWnt5a knockout embryos (Cervantes et al., 2009). The dynamics
of Wnt5a functioning are not completely understood to date. Given
that endogenous Wnt5a expression in the gut is most prominent
between 10.5 and 13.5 dpc and diminishes after that might be an
indication that Wnt5a is most crucially involved in developmental
elongation processes in this speciﬁc period. However, it remains to
be clariﬁed whether the functioning of Wnt5a extends beyond this
stage. Relevant postnatal roles of Wnt5a have been suggested
based upon associative Wnt5a expression studies and in vitro
studies. Hence, enhanced Wnt5a expression has been observed in a
variety of human diseases, including inﬂammatory conditions
(Blumenthal et al., 2006; Pereira et al., 2009), metabolic disorders
(Kikuchi et al., 2011; Oh and Olefsky, 2010; Ouchi et al., 2010) and
a multitude of cancer types, among which colorectal cancer
(Gregorieff et al., 2005; Pukrop and Binder, 2008; Smith et al.,
1999). Also, a wide variety of in vitro studies have implicated
Wnt5a in multiple cellular processes, including cell growth, differ-
entiation, migration and invasion (Cheng et al., 2008; Kikuchi et al.,
2011; Nishita et al., 2010a; Pukrop and Binder, 2008). Despite these
supportive data, solid in vivo evidence for a signiﬁcant postnatal
impact of Wnt5a is lacking. To date, it has not been possible to
modulate and investigate the activities of Wnt5a in an adult
organism. We have generated an inducible Wnt5a transgenic
mouse model, enabling in vivo determination of the relevance
and activities of Wnt5a during desired time-frames. Transgenic
Wnt5a expression was induced during speciﬁc time-frames of
embryonic development and during adulthood, followed by a
phenotypic analysis focusing on the intestinal tract.Materials and methods
Generation of inducible Wnt5a mouse model and in vivo doxycyline
administration
To generate the TetO-Wnt5a construct, a 1.1 kb XbaI fragment
was isolated from a TetO-FLAG-Wnt5a vector (kindly provided
by Dr. R. Nusse, Stanford University, CA), and inserted into thepTRE-Tight vector containing an additional 0.68 kb b-globin
intron. The 2.4 kb expression cassette was XhoI digested from
the plasmid backbone, gel-puriﬁed and injected into C57Bl/6J
oocytes by standard procedures. TetO-Wnt5a positive founders
were identiﬁed by PCR using transgene speciﬁc primers SCT2F (5’-
CTACACCCTGGTCATCATCC) and mWnt5AFLAG-R (5’-TCGTACCTA
GAGACCACCAAG).
TetO-Wnt5a mice were interbred with hnRNP-rtTA2S-M2 mice
(Katsantoni et al., 2007), obtaining double transgenic mice. Wild-
type and single transgenic mice were generated simultaneously
and served as control animals. Doxycycline (dox) was adminis-
tered via the drinking water (2 mg/ml dox, 5% sucrose). Induction
during embryogenesis was performed by administering dox to
timed pregnant females.
All mice were generated, bred and maintained under speciﬁc
pathogen-free conditions at the animal facility of the Erasmus MC
University Medical Center. All animal experiments were approved
by the Institute’s Animals Ethics Committee and were carried out
in accordance with Dutch legislation.
Cell culture and treatments
Tail ﬁbroblasts were isolated from adult mice by incubating tail
tips in Dulbecco’s modiﬁed essential medium (DMEM, Lonza)
complemented with 0.14 U/ml Blendzyme (Roche), 1% antibio-
tics/antimycotics (Gibco) and 0.5% fetal bovine serum (FBS, Sigma
Aldrich) for 3 h at 37 1C. Mixture was put on a cell strainer and cells
were cultured in DMEM with 1% antibiotics/antimycotics and 10%
FBS at 37 1C, 5% CO2. Mouse embryonic ﬁbroblasts (MEFs) were
isolated from embryos of 13.5–15.5 dpc and cultured and trans-
fected as previously described (van Veelen et al., 2011). When
indicated, cells were induced with 1 mg/ml dox. HEK293T cells
were cultured in DMEM with 10% FBS, 1% p/s at 37 1C, 5% CO2.
b-catenin reporter assay
b-catenin reporter assay in MEFs was performed as previously
described (van Veelen et al., 2011). A Ror2 expression vector
(kindly provided by Dr. A. Kikuchi, Osaka University, Japan) was
co-transfected to assure sufﬁcient receptor availability for the
transgenic Wnt5a. Transfected cells were provided with 1 mg/ml
dox for 24 h of which the ﬁnal 16 h cells were simultaneously
stimulated with either 25% of L-control or L-Wnt3a conditioned
medium. Luciferase activities were measured using the
dual-luciferase reporter assay system (Promega) and a LUMIstar
luminometer. Assays were performed in duplicate and
performed twice.
Immunoblotting
Cultured cells and snap-frozen intestinal tissue specimens
were lysed in Laemmli sample buffer containing 0.1 M DTT and
incubated at 95 1C for 10 min. Western blotting was performed
according to standard chemoluminescent procedures or using
ﬂuorescent Odyssey immunoblotting (LI-COR Biosciences,
Lincoln, NE, USA) (van Veelen et al., 2011). Antibodies are
indicated in Supplementary Table I. Quantiﬁcation was performed
using Odyssey Li-Cor software.
Skeletal preparations and staining
Embryos were skinned, eviscerated, ﬁxed overnight in 96%
ethanol containing 1% glacial acetic acid. Cartilage was stained
overnight in 0.5 mg/ml Alcian Blue. Soft tissues were dissolved in
1.5% potassium hydroxide for 3 h followed by staining of bone
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hydroxide/20% glycerol.
Tissue processing and histology
Adult intestines, whole embryos or embryonic intestines were
isolated, washed in PBS and ﬁxed overnight in 4% PBS-buffered
paraformaldehyde (4% PFA) at 4 1C. Fixed embryonic intestines
were pre-embedded in 5% bacto-agar (BD) in PBS and cut into 6–8
pieces enabling proper identiﬁcation of the different regions. All
mouse materials were embedded in parafﬁn according to routine
protocols.
Haemotoxylin eosin (HE), Periodic Acid Schiff (PAS) and Alka-
line Phosphatase (AP) stainings were performed according to
routine protocols. Immunohistochemistry was performed using
antigen retrievals and antibodies as indicated in Supplementary
Table II. Visualization was performed using the Envisionþ System
or StreptABCcomplex/HRP (Dako).
RNA isolation, cDNA synthesis and quantitative PCR
RNA was isolated from snap-frozen embryonic intestines and
adult duodenum tissues using Nucleospin RNA II Kit (Machery-
Nagel, Du¨ren, Germany), followed by cDNA generation using
iScript cDNA Synthesis Kit (Bio-Rad). Quantitative PCR was per-
formed using Sensimix SYBR Green (Bioline) or TaqMan (in case of
Axin2/Actb) Gene Expression Assays (Applied Biosystems) and run
in the IQ5 Real time PCR detection system (Bio-Rad). Primers are    du
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Tight regulation of functionally active Wnt5a protein in TetO-Wnt5a
transgenic mouse model
We generated TetO-Wnt5a mouse founder lines carrying the
mouseWnt5a gene under the control of a Tet-inducible promoter.
This promoter is inducible by the rtTA transcription activator in a
doxycyline (dox) dependent manner. TetO-Wnt5a founders were
crossed with the hnRNP-rtTA transgenic mouse line, which drives
ubiquitous expression of the rtTA2S-M2 gene (Katsantoni et al.,
2007). Dox administration allows transgenic Wnt5a induction
only in double transgenic mice carrying both TetO-Wnt5a and
hnRNP-rtTA constructs. Wnt5a expressing founders were identi-
ﬁed by culturing tail ﬁbroblasts, providing a founder with robust
Wnt5a protein expression upon dox administration without
displaying Wnt5a expression in controls (Fig. 1A). Similar results
were observed in mouse embryonic ﬁbroblasts (MEFs) (Figs. 1B
and S1A). To validate the functionality of the transgenic Wnt5a
protein, we determined its capability to inhibit canonical Wnt/b-
catenin signaling. MEF lines of control and double transgenic
genotypes were stimulated with Wnt3a to enhance b-catenin
signaling and doxycyline was added to induce transgenic Wnt5a
(Fig. 1B, upper panel). b-catenin mediated transcription was    col     du     col    du    col     du     col
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(Fig. 1B, lower panel). This indicates that upon dox induction in
double transgenic MEFs, the cells produce functionally active
Wnt5a protein.
In vivo dox administration successfully induced transgenic
Wnt5a expression in double transgenic mice exclusively, as
shown by immunoblotting and immunohistochemistry (Fig. 1C–
E). Induction was a rapid process since transgenic Wnt5a was
detected already within 24 h following dox administration (Fig.
S1B). In adult and embryonic mice, expression of transgenic
Wnt5a protein was veriﬁed along the entire intestinal tract by
immunohistochemistry (data not shown). When induction
was performed during embryonic development from 10.5 dpc
onwards, transgenic Wnt5a expression was observed in gut
mesenchyme and epithelium at 13.5 dpc, shifting towards a
predominant epithelial expression pattern at 18.5 dpc (Fig. 1D).
In the adult intestine, induced Wnt5a was most prominent in the10.5 13.5 5.815.6
dp
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although less abundant, displaying an overall diffuse staining in
addition to several intensely stained individual cells (Fig. 1E).
Wnt5a expression was not detected in muscle cells. Although all
following experiments were performed with above described
TetO-Wnt5a founder line unless mentioned differently, we vali-
dated a second TetO-Wnt5a founder which displayed a mosaic
Wnt5a expression pattern (Figs. 6C and S1C).
Induced Wnt5a expression deregulates embryonic development
Wnt5a is indispensable during mouse development, since its
absence results in defective embryonic outgrowth and perinatal
lethality (Yamaguchi et al., 1999). We induced Wnt5a expression
during several time-frames of embryogenesis to investigate the
developmental consequences of overexpressing Wnt5a. Dox-
induced double transgenic mice will be further referred to asc
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nt5aind (lower) phenotype. Limbs and tails are not complete in this ﬁgure panel.
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Fig. 3. Induced Wnt5a expression disturbs embryonic intestinal elongation. Gastro-
intestinal structures of 18.5 dpc embryos induced from 10.5 dpc onwards.
(A) Overview of gastrointestinal tracts, (B) higher magniﬁcation of the large
intestine and (C) cecum. (D) The Wnt5aind embryonic anus is imperforated.
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induction from 6.5 dpc to 13.5 dpc resulted in severe develop-
mental defects (Fig. 2A). Externally, primarily the head, limbs and
tail showed outgrowth defects. As the Wnt5aind embryos had
already died in utero at 13.5 dpc, necrosis precluded a more
detailed examination of these embryos. Starting induction of
transgenic Wnt5a later, i.e. at 10.5 dpc, did not result in embryo-
nic lethality but led to facial deformities and shortened limbs and
tail (Fig. 2B–C). Similar defects were observed using our mosaic
Wnt5a founder (Fig. S2A). Later dox inductions, from 13.5 dpc to
18.5 dpc, did not lead to apparent developmental defects in
Wnt5aind embryos (Fig. S2B). Examination of skeletal stainings
provided insight regarding the basis of the externally visible
defects in late-stage embryos that had been induced from
10.5 dpc onwards (Fig. 2D). The tails of Wnt5aind embryos were
clearly shortened, caused by a decreased number of vertebrae
(Fig. 2E). In the head, the most severely shortened bones are those
in the upper jaw, while lower jaw elements were mildly shor-
tened (Fig. 2F). Limb shortening was chieﬂy caused by deﬁcient
outgrowth of individual skeletal elements, including stylopodal
and zeugopodal bones which appear thicker than normal as well
(Fig. 2G). Autopods appeared underdeveloped with shorter and
thicker digits and a delay of ossiﬁcation events, but no obvious
loss of skeletal elements as has been reported for Ror2 and Wnt5a
knockout embryos was observed. Together, these experiments
revealed that Wnt5a overexpression causes embryonic defects
resembling those observed in Wnt5a KO and Ror2 KO embryos,
affecting the structures whose progenitors normally express
Wnt5a in a graded fashion. Time dependency, i.e. before
13.5 dpc, of the Wnt5a overexpression phenotype matches the
period in which endogenous Wnt5a is normally expressed most
abundantly (Cervantes et al., 2009; Gavin et al., 1990; Lickert
et al., 2001; Yamada et al., 2010; Yamaguchi et al., 1999).
Induced Wnt5a expression disturbs embryonic intestinal elongation
In the developing gastrointestinal tract, Wnt5a expression is
detected in the mesenchyme of the caudal midgut, rostral hindgut
and stomach fundus (Cervantes et al., 2009; Lickert et al., 2001;
Yamada et al., 2010). Loss of Wnt5a leads to severely shortened
gastrointestinal tracts (Cervantes et al., 2009). Interestingly, we
found that time-speciﬁc Wnt5a overexpression from 10.5 dpc
until 18.5 dpc also resulted in drastic shortening of the small
and large intestine, cecum and stomach (Fig. 3A–C). Furthermore,
Wnt5aind embryos displayed an imperforate anus (Fig. 3D), as has
also been observed in Wnt5a KO embryos (Cervantes et al., 2009).
A similar phenotype was revealed using the mosaic TetO-Wnt5a
founder line, albeit less drastic (Fig. S2C). The phenotype was not
observed when Wnt5a expression was induced from 13.5 dpc
onwards (Fig. S2D). This indicates that the activities by which
induced Wnt5a interferes with intestinal elongation mainly take
place between 10.5 and 13.5 dpc, which is the phase of intestinal
elongation when a rapid increase in length occurs and when
Wnt5a is normally expressed most abundantly. Together, our data
demonstrate that ubiquitous Wnt5a overexpression causes gas-
trointestinal elongation defects resembling those observed in
Wnt5a KO and Ror2 KO embryos, when induced from 10.5 dpc
but not from 13.5 dpc onwards, reﬂecting the time-frame when
Wnt5a is normally expressed at highest levels (Cervantes et al.,
2009; Gavin et al., 1990; Lickert et al., 2001; Yamada et al., 2010;
Yamaguchi et al., 1999).
Wnt5a does not alter cell fate during intestinal development
To investigate whether the differentiation state of the embryo-
nic Wnt5aind shortened intestines was altered, intestines ofembryos induced from 10.5 dpc until 18.5 dpc were isolated and
analyzed extensively. Hematoxylin eosin (HE) staining revealed
no histological aberrations in Wnt5aind embryonic intestines
(Fig. 4A). Presence of goblet and enteroendocrine cells was not
inﬂuenced by Wnt5a induction as determined by Periodic Acid
Schiff (PAS), Muc2 and synaptophysin staining (Figs. 4B–C and
S3A). Smooth muscle actin (SMA) staining showed normal
smooth muscle layer development and expression of homeobox
protein Cdx2 was unaffected (Fig. 4D–E). Furthermore, no abnor-
mal localization of either b-catenin or E-cadherin expression was
observed in the intestines of Wnt5aind embryonic intestines
(Figs. 4F and S3B). Proliferation of intestinal cells determined by
phospho-histone H3 staining revealed no gross differences in
proliferation rate among the different genotypes (Fig. 4G). Alto-
gether this indicated that Wnt5a has no impact on embryonic
intestinal cell fate, in line with similar ﬁndings inWnt5a knockout
embryos (Cervantes et al., 2009).
Induced Wnt5a expression is well-tolerated in the adult mouse
intestine
To determine the consequences of increased Wnt5a expression
postnatally, we performed doxycycline inductions in adult mice
for multiple durations, including 1 day, 1 week and 3–5 months.
During the induction period, the overall appearance of the mice
remained unaffected. Following the inductions, mice were exam-
ined for abnormalities with a speciﬁc focus on the intestinal tract.
No gross abnormalities in length and macroscopic appearance
were observed as a consequence of transgenic Wnt5a induction.
HE staining revealed no histological abnormalities in the
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inal cell types including PAS for goblet cells, synaptophysin for
enteroendocrine cells, lysozyme for Paneth cells, SMA for muscle
and stromal cells and alkaline phosphatase (AP) for enterocytes
all showed no changes upon transgenic Wnt5a expression in adult
mice (Figs. 5B–E and S3C). Immunohistochemical staining of
b-catenin revealed no aberrant expression, displaying membra-
nous and nuclear b-catenin in Wnt5aind intestine comparable to
corresponding control mice (Fig. 5F). E-cadherin staining was
unaffected (Fig. S3D) and also proliferation of intestinal cells was
unaltered (Fig. 5G). Altogether, induced Wnt5a expression is
tolerated well by adult mice and does not affect postnatal
intestinal homeostasis and cell fate.
Wnt5a downregulates Ror2 protein in embryonic and adult intestine
As Ror2 is an important receptor mediating Wnt5a signaling,
we determined Ror2 protein expression by immunohistochemis-
try. All embryos were subjected to dox induction from 10.5 dpc13.5 dpc
18.5 dpc
Wnt5a
Ror2
Adult
Control
Fig. 6. Wnt5a downregulates Ror2 protein in embryonic and adult intestine. All embryos we
for 1 week. In adults, intensely stained stromal cells assumingly represent IgG pro
(A) Immunohistochemical Ror2 staining of cross-sections of 13.5 and 18.5 dpc embryo
adult intestine of control genotype (lower panel). (B) Drastically reduced Ror2 express
18.5 dpc Wnt5aind embryonic intestine using the alternative TetO-Wnt5a founder (uppe
Ror2 RNA expression in 17.5 dpc embryonic and adult intestine respectively.onwards and adult mice were induced for 1 week. Examination of
Ror2 protein expression in 13.5 and 18.5 dpc embryonic intes-
tines of control genotypes revealed abundant expression in the
mesenchyme and muscle layers, and membranous Ror2 in the
epithelium (Fig. 6A). In the adult intestine of control genotypes,
Ror2 protein levels were strongly reduced compared to embryo-
nic stages, presenting mainly in the muscle layers while along the
crypt-villus structures only low level expression was observed in
crypt compartments (Fig. 6A, lower panel). Reduced Ror2 expres-
sion in adult compared to embryonic intestine was conﬁrmed on
RNA level (data not shown). Interestingly, we found that intest-
inal Ror2 protein expression was strongly reduced in correspond-
ing Wnt5aind mice (Fig. 6B). This Ror2 downregulation was
particularly clear at embryonic stages, when a major reduction
in all gut compartments, including muscle, epithelium and
mesenchyme was observed. In the adult intestine, Wnt5a induc-
tion reduced the expression of Ror2 in muscle cells and to barely
detectable levels in crypt cells. Notably, using the alternative
founder with a mosaic Wnt5a expression pattern we also0.1
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Wnt5aind intestines, even in regions that do not overexpress
Wnt5a. This indicates that secreted transgenic Wnt5a ligands
acted in a paracrine fashion (Fig. 6C). Ror2 RNA levels were not
affected in the Wnt5aind intestines of both the embryonic and
adult stages, despite the clear increase in Wnt5a RNA production
(Fig. 6D and E), demonstrating that Wnt5a does not regulate Ror2
expression at the level of RNA production. In contrast to the
reduced Ror2 protein levels that we observed in Wnt5aind
embryonic intestines, we did not observe altered Ror2 protein
expression in the intestines of homozygous Wnt5a knockout mice
compared to wildtype or heterozygous littermates (Fig. S4A–B).
We did however observe downregulation of endogenous Ror2
protein on cultured HEK293T cells and MEFs upon Wnt5a0.0
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Induced Wnt5a expression enhances downstream signaling in
embryonic intestine
The ﬁnding that induced Wnt5a expression reduces Ror2
protein levels raised the question what the consequences are for
downstream Wnt5a signaling. We determined the levels of
Wnt5a downstream targets in embryonic intestines (induced
10.5–17.5 dpc) by immunoblotting. Ror2 protein levels were
strongly reduced in Wnt5aind mice, conﬁrming the immunohis-
tochemical analyses (Fig. 7A). Several studies have shown that
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Nishita et al., 2010b). In line with this, we observed a reproducible
1.4-fold increase in phosphorylated Dvl2 levels (upper bands).
Moreover, levels of the Wnt5a downstream target pJNK were
clearly increased in Wnt5aind embryonic intestines, showing a
1.8 fold increase. Thus, although Ror2 levels are strongly reduced
in Wn5aind embryos, Wnt5a signaling is enhanced. Despite
possible modulation of Wnt/b-catenin signaling by Wnt5a, we
observed no changes in RNA expression levels of the b-catenin
target gene Axin2 in Wnt5aind embryonic intestines (Fig. 7B).
Similar analyses were performed on duodenal tissues of adult
animals induced for 1 week. Immunoblotting for Ror2 revealed a
2-fold downregulation in Wnt5aind adult intestines, and con-
ﬁrmed the relatively low expression compared to the embryonic
situation (Fig. 7C). No signiﬁcant differences in pDvl2 were
observed upon Wnt5a induction, whereas pJNK levels were at
most slightly increased. In accordance with the embryonic intes-
tines, Axin2 RNA expression levels were not changed in adult
Wnt5aind duodenum (Fig. 7D). Taken together, despite the drastic
downregulation of Ror2 protein in Wnt5aind intestines, embryonic
levels of pDvl2 and pJNK were enhanced, indicating a net gain of
Wnt5a signaling. In the adult Wnt5aind intestine, enhanced
Wnt5a signaling was not clearly observed.Discussion
Wnt5a undoubtedly plays a signiﬁcant role during embryonic
development, as indicated by multiple outgrowth defects affect-
ing limbs, tail, face and the gastrointestinal tract in Wnt5a
knockout mice (Cervantes et al., 2009; Yamaguchi et al., 1999).
However, not much is known on the dynamics of Wnt5a func-
tioning to date. Although endogenous Wnt5a expression in the
gut is most prominent before 13.5 dpc and diminishes after that
period, it is not known whether Wnt5a is involved beyond this
time-frame of development. In addition, relevant postnatal roles
of Wnt5a have been suggested based upon associative Wnt5a
expression studies and in vitro studies. Unfortunately, it has not
been possible to date to modulate and investigate the activities of
Wnt5a in an adult organism as a consequence of the perinatal
lethality of Wnt5a knockout mice. We have generated an induci-
ble Wnt5a transgenic mouse model, and induced transgenic
Wnt5a expression during speciﬁc time-frames of embryonic
development and during adulthood, followed by a phenotypic
analysis focusing on the intestinal tract.
Regarding the consequences of Wnt5a induction in embryos
from 10.5 dpc onwards, the observed defects including shortened
snout, limbs and tail resemble those seen in Wnt5a and Ror2
knockouts and correspond to structures in whose progenitors
Wnt5a is normally expressed (DeChiara et al., 2000; Gavin et al.,
1990; Takeuchi et al., 2000; Yamada et al., 2010; Yamaguchi et al.,
1999). Our results demonstrate that embryonic Wnt5a gain of
function results in a phenotype resembling a Wnt5a loss of
function situation, a phenomenon reported more often
(Ohkawara et al., 2011; Veeman et al., 2003). Importantly, these
phenotypic defects were not observed when Wnt5a was induced
from 13.5 dpc onwards. Together with the knowledge that Wnt5a
is most prominently expressed before 13.5 dpc, this suggests that
developmental outgrowth processes involving Wnt5a mainly
occur before 13.5 dpc. Similar phenotypical resemblance and
time-dependency of the phenotype apply to the gastrointestinal
tract. When we induced transgenic Wnt5a from 10.5 dpc
onwards, intestinal length was severely reduced, as is observed
in Wnt5a knockout embryos (Cervantes et al., 2009). Intestinal
elongation was not affected when Wnt5a was induced from
13.5 dpc onwards. During normal embryogenesis, intestinalWnt5a expression is restricted to the mesenchyme of the caudal
midgut and rostral hindgut, thereby providing positional infor-
mation directing intestinal elongation (Cervantes et al., 2009;
Lickert et al., 2001; Yamada et al., 2010). However, both in the
Wnt5a overexpression and Wnt5a knockout situation, such a
regionalized endogenous Wnt5a gradient is lost, resulting in lack
of positional cues required for directional elongation, likely
explaining the comparable elongation defects. Supportively, time
dependency of our Wnt5a-mediated gut phenotype coincided
with the period during which endogenous Wnt5a is normally
expressed most prominently, i.e. between 10.5 and 13.5 dpc.
Together, our data indicate that Wnt5a is involved in intestinal
elongation processes that occur before 13.5 dpc and that proper
regionalized Wnt5a expression between 10.5–13.5 dpc is
required for complete elongation (Cervantes et al., 2009; Lickert
et al., 2001; Yamada et al., 2010). An alternative explanation for
the observed intestinal shortening might be presented by the
strongly downregulated Ror2 protein levels in our Wnt5aind
embryos, thereby phenocopying a Ror2 knockout situation. How-
ever, we do not consider this a solid explanation, given the
residual Ror2 protein expression and increased levels of pDvl2
and pJNK in Wnt5aind embryonic intestines, indicating a net gain
of Wnt5a signaling. Although we cannot exclude that the
enhanced signaling is mediated via alternative Wnt5a receptors,
such as the Frizzleds, it suggests that Ror2 reduction has not
hampered Wnt5a signaling. Ror2 has been shown to undergo
clathrin-mediated internalization upon Wnt5a stimulation and to
present in early endosomes (Akbarzadeh et al., 2008; O’Connell
et al., 2010). Subsequent routes taken by Ror2 remain elusive.
Other Wnt5a-related receptors including Fz2, Fz4 and Fz5 may
undergo lysosomal degradation following internalization (Chen
et al., 2003; Rives et al., 2006; Terabayashi et al., 2009). Our
results support the possibility that Ror2 follows this route as well,
involving a process more often observed after receptor–ligand
endocytosis where receptors are either recycled to the membrane
or directed to lysosomes for degradation (Acconcia et al., 2009).
As shown for the EGF receptor, high ligand exposure directs more
receptors towards lysosomal degradation as a mechanism to
restrict signaling. This seems a likely scenario for Ror2 to follow
the high Wnt5a levels induced in our mice.
Beyond the involvement of Wnt5a in embryonic development,
relevant postnatal roles of Wnt5a have been suggested based upon
associative Wnt5a expression studies and in vitro studies. However,
our data show that the adult mouse intestine is not affected by
induced Wnt5a expression, neither showing histological aberrations
nor changes in b-catenin signaling. This might appear surprising
since Wnt5a can potentially interact with multiple signaling path-
ways and has been attributed modulating capacities with regard to
cell proliferation, migration and differentiation (Cheng et al., 2008;
Kikuchi et al., 2011; Nishita et al., 2010a; Pukrop and Binder, 2008).
On the other hand, our results imply that the main function of
Wnt5a exists during embryonic outgrowth events, which obviously
do not occur during the maintenance of adult intestinal home-
ostasis. Supportively, levels of endogenous Wnt5a expression in
adult intestine are relatively low compared to levels in developing
gut (Cervantes et al., 2009; Gregorieff et al., 2005; Lickert et al.,
2001; Yamada et al., 2010), also applying to Ror2 expression levels
(Fig. 6A–C). Considering this, it might be speculated that sufﬁcient
Ror2 expression is needed to acquire an effect following Wnt5a
induction. However, embryonic Wnt5a induction from 13.5 dpc
onwards did not result in a phenotype despite abundant Ror2
presence, showing that the phenotypic consequences do not entirely
depend on the presence of Ror2. Extra-intestinal aberrations result-
ing from postnatal hnRNP-rtTA-driven Wnt5a expression were not
observed, although other adult organs were not investigated in
sufﬁcient detail to allow ﬁrm conclusions.
E.R.M. Bakker et al. / Developmental Biology 369 (2012) 91–100100Taken together, our results indicate a role for Wnt5a during a
restricted time-frame of embryonic development, but suggest no
impact during homeostatic postnatal stages. Conditional Wnt5a
knockout studies in adult animals could ideally further support
our ﬁndings. Furthermore, as increased Wnt5a expression is
typically observed in diseased situations, additional triggers
may be needed to reveal postnatal activities of Wnt5a. In the
future, this can be investigated by exposing our newly generated
inducible Wnt5a mouse model to speciﬁc stress conditions or
combining it with disease models.Acknowledgments
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